273 related articles for article (PubMed ID: 8747462)
1. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
[TBL] [Abstract][Full Text] [Related]
2. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
[TBL] [Abstract][Full Text] [Related]
3. [The fasciculin-acetylcholinesterase interaction].
Marchot P
J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
[TBL] [Abstract][Full Text] [Related]
4. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
[TBL] [Abstract][Full Text] [Related]
5. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
Bourne Y; Taylor P; Marchot P
Cell; 1995 Nov; 83(3):503-12. PubMed ID: 8521480
[TBL] [Abstract][Full Text] [Related]
8. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
9. Electron paramagnetic resonance reveals altered topography of the active center gorge of acetylcholinesterase after binding of fasciculin to the peripheral site.
Sentjurc M; Pecar S; Stojan J; Marchot P; Radić Z; Grubic Z
Biochim Biophys Acta; 1999 Mar; 1430(2):349-58. PubMed ID: 10082962
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
[TBL] [Abstract][Full Text] [Related]
12. Site of fasciculin interaction with acetylcholinesterase.
Radić Z; Duran R; Vellom DC; Li Y; Cervenansky C; Taylor P
J Biol Chem; 1994 Apr; 269(15):11233-9. PubMed ID: 8157652
[TBL] [Abstract][Full Text] [Related]
13. NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom.
Albrand JP; Blackledge MJ; Pascaud F; Hollecker M; Marion D
Biochemistry; 1995 May; 34(17):5923-37. PubMed ID: 7727450
[TBL] [Abstract][Full Text] [Related]
14. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
Rosenberry TL; Rabl CR; Neumann E
Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
[TBL] [Abstract][Full Text] [Related]
15. Allosteric control of acetylcholinesterase catalysis by fasciculin.
Radić Z; Quinn DM; Vellom DC; Camp S; Taylor P
J Biol Chem; 1995 Sep; 270(35):20391-9. PubMed ID: 7657613
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization.
Frobert Y; Créminon C; Cousin X; Rémy MH; Chatel JM; Bon S; Bon C; Grassi J
Biochim Biophys Acta; 1997 May; 1339(2):253-67. PubMed ID: 9187246
[TBL] [Abstract][Full Text] [Related]
17. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
Bui JM; Radic Z; Taylor P; McCammon JA
Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.
Kryger G; Silman I; Sussman JL
J Physiol Paris; 1998; 92(3-4):191-4. PubMed ID: 9789806
[TBL] [Abstract][Full Text] [Related]
19. 1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom.
le Du MH; Marchot P; Bougis PE; Fontecilla-Camps JC
J Biol Chem; 1992 Nov; 267(31):22122-30. PubMed ID: 1429564
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
Radić Z; Kirchhoff PD; Quinn DM; McCammon JA; Taylor P
J Biol Chem; 1997 Sep; 272(37):23265-77. PubMed ID: 9287336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
